Skip to main content
. 2019 Feb 8;40(8):947–955. doi: 10.1093/carcin/bgz033

Table 2.

Uni- and multivariate Cox-regression analyses for the prediction of overall survival

Univariate Cox-regression Multivariate Cox-regression
Parameter P-value Hazard ratio (95% CI) P-value Hazard ratio (95% CI)
suPAR (>5.956 ng/ml) 0.001 2.304 (1.392–3.813) 0.017 2.533 (1.185–5.418)
Leukocyte count 0.926 0.997 (0.930–1.068)
CRP 0.033 1.006 (1.000–1.011) 0.180 1.005 (0.998–1.013)
Platelets 0.751 1.000 (0.997–1.002)
AST 0.178 1.002 (0.999–1.005) 0.088 1.003 (0.999–1.007)
Bilirubin 0.098 1.051 (0.991–1.116) 0.107 0.916 (0.823–1.019)
ALP 0.873 1.000 (0.999–1.001)
LDH 0.480 0.992 (0.972–1.013)
Creatinine 0.223 1.706 (0.772–4.031) 0.557 1.325 (0.518–3.393)
BMI 0.927 0.998 (0.948–1.050)
ECOG PS 0.221 1.192 (0.899–1.581) 0.251 0.797 (0.540–1.175)
Age 0.059 1.024 (0.999–1.050) 0.198 1.022 (0.989–1.055)
Sex 0.663 0.889 (0.547–1.443)
T-stage 0.271 1.318 (0.807–2.153)

ALP, alkaline phosphatase; AST, aspartate transaminase; BMI, body mass index; CRP, C-reactive protein; ECOG PS, ‘Eastern Cooperative Oncology Group’ performance status; LDH, lactate dehydrogenase.